Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study). - Poewe,W.H.; Deuschl,G.; Gordin,A. (Acta Neurol Scand, 2002)